In North America, we market and sell our products principally through our direct sales organization supported by service operations located in Orange County, CA; Dallas, TX; Portland, OR; New Haven, CT; and Ottawa, Canada.
In Europe, we market and sell our products primarily through our direct sales and service operations in the United Kingdom, the Netherlands, France and Germany.
In South Korea, we market and sell our products directly through our wholly owned South Korean subsidiary. In Japan and Taiwan, we operate with distribution support from our United Kingdom and South Korea offices. We are currently assessing our Asian organization and we expect to increase the resources allocated to this region during fiscal 2003.
Our total revenue includes amounts from certain individual customers that exceed 10% of our total revenue. For the year ended December 31, 2002, Philips was the only customer who exceeded 10% of our revenue, accounting for 11% of our revenue. In 2001, Infineon AG represented 17% and Philips represented 15% of our total revenues respectively. Our largest customers may vary from year to year depending upon, among other things, a customers budget for capital expenditures, plans for new fabrication facilities and new product introductions.
We provide
customers with evaluation systems of our new products as part of our sales efforts.
The provision of evaluation systems is an important step in the lengthy sales
cycle. The average duration of an evaluation period for systems is approximately
one year. Consequently, as we expand our sales efforts, particularly in the
low k market, we believe that a significant increase in our investment in demonstration
and evaluation systems may be needed.
We have an international customer support group at Newport, UK in addition to the local office service and support staff at our regional centers. We also have a dedicated training suite at our Newport facilities housing a clean room with complete systems and the latest generation training aids. The Newport based support team is divided into CVD, PVD and plasma etch groups responsible for quality and technical support, a training and support documentation group and a spares supply group.
Research, Development and Engineering
We believe that our future success will depend primarily upon our ability to continue to improve our systems and technologies and to develop new products that compete effectively on the basis of total cost of ownership and technical performance. These technologies and systems will also need to meet customer requirements and emerging industry standards. Accordingly, we devote a significant portion of our personnel and our financial resources to research and development programs and seek to maintain close relationships with our customers in order to remain responsive to their product needs. This commitment is evidenced by the 11% increase in research and development expenditures in the year ended December 31, 2002 as compared to the prior year, despite the downturn in the semiconductor industry.
As of December
31, 2002, we employed 75 professional and technical personnel in research, development
and engineering. Our research and development group is responsible for identifying
new technology applications and developing processes to meet customer requirements.
Major research and development programs currently address CVD deposited dielectrics
for ILD/IMD and shallow trench isolation gap fill applications and ultra low
k dielectrics for copper damascene applications, PVD and MOCVD deposited barrier/liner/seed
applications and advanced oxide/low k and silicon etch applications for silicon
integrated circuits and the deposition and etching of critical layers in compound
semiconductor and planar optical waveguide devices.
Our expenditure for research and development during the fiscal years 2002, 2001 and 2000 were $10.7 million, $9.7 million and $8.4 million, respectively
Manufacturing
We manufacture most of our key technology components for our products at our Newport, United Kingdom facility, where substantially all of our long-lived assets are maintained. This approach has enabled us to ensure quality control and compliance with government regulation and reduce dependence on third party suppliers. Our United Kingdom operations are ISO 9001 compliant.
7
Our Newport facility has
world-class
facilities which are built and operated at the high levels of cleanliness
required in the semiconductor industry. Our manufacturing and final test area
is class 1000 representing a high level of cleanliness (a class is a standard definition which represents a number of particles per million, the smaller the number of particles the cleaner the facility). With a class 100 engineering clean room and a class 10 process and product demonstration room, our engineering and customer support areas are even cleaner. We also have a dedicated training suite of classrooms and a clean workshop stocked with our products, both current and former generations, where we are able to train our own and our customers engineers. We also operate two additional sites near the Newport facility where assemblies are made, a sheet metal fabrication workshop producing enclosures, panels and other parts and a CNC machinery center, producing chamber components and other parts and wafer transport assemblies. In order to ensures that our facilities remain competitive in both quality and price, and to help cover fixed costs, the CNC facility also produces
products for third parties.
Competition
The markets we serve are highly competitive and subject to rapid technological change. Historically, new technologies have only gained acceptance when industry leaders have concurrently adopted such new technologies. Significant competitive factors include timing of new product offerings, system performance, cost of ownership, size of installed base, depth and breadth of product line and customer support.
We face significant competition from various suppliers of systems that utilize similar or alternative technologies. Competitors range from very large, well capitalized corporations with a diversified product portfolio to smaller companies that compete with a single innovative product. In the CVD market, our primary competitors are Applied Materials, ASMI, Novellus and Unaxis, as well as other CVD manufacturers and track manufacturers for spin on glass, or SOG, deposition, such as Tokyo Electron. In the PVD market, we face competition from suppliers such as Anelva, Applied Materials, Novellus, Ulvac, Unaxis, and Veeco. In the etch market, we face competition from suppliers including Applied Materials, Hitachi, Lam Research, Tegal, Tokyo Electron and Unaxis. Virtually all of these competitors are substantially larger companies, some with broader product lines. They have well established reputations in the markets in
which we compete, greater experience with high volume manufacturing, broader name recognition, substantially larger customer bases, and substantially greater financial, technical, manufacturing and marketing resources.
We have granted non-exclusive, worldwide, paid-up licenses of our M0RI source and Force Fill PVD technologies to Applied Materials and granted a non-exclusive, worldwide, paid-up license of our M0RI source technology to Lam Research. As a result, in the future our PVD and etch products may have to compete with products of Applied Materials or Lam Research based on our technologies. The license agreements do not preclude us from utilizing, or licensing to other third parties, the licensed technologies.
Backlog
As of December 31, 2002, our
backlog was approximately $8.5 million, as compared to approximately $13.7 million at December
31, 2001. Our backlog consists of system purchase orders that provide for delivery within the
following year and the unearned revenue of systems previously shipped. Backlog includes only
systems for which a purchase order has been received and a delivery date assigned. Backlog at
December 31, 2002 includes one system for $1.6 million for which the purchase order is subject
to our customer receiving final United States government approval of funding. Orders are
typically subject to cancellation or delay by the customer with limited or no penalties.
The reduction in our backlog is directly attributable to the
continuing and protracted downturn in the semiconductor industry and the resulting low
order volume in 2002. Because of possible changes in delivery schedules and cancellations of orders,
the stated backlog is not necessarily indicative of sales for any
future period nor is a backlog any assurance that we will realize profit from filling
these orders.
Intellectual Property
We rely on a variety of types of intellectual property protection to protect our proprietary technology, including patent, copyright, trademark and trade secret laws, non-disclosure agreements, and other intellectual property protection methods. We currently hold 31 US and 56 foreign patents. As of December 31, 2002, we have 32 patent applications pending in the US and 169 patents pending in the rest of the world, and we intend to file additional patent applications as appropriate. The issued patents and any subsequent issued patent arising from our pending applications expire between 2009 and 2022.
Our success and ability to compete depends in large part upon protecting our proprietary technology. We rely on a combination of patent, trade secret, copyright and trademark laws, non-disclosure and other contractual agreements and technical measures to protect our proprietary rights.
8
There can be
no assurance that patents will be issued on our pending patent applications
or that competitors will not be able to legitimately ascertain proprietary information
embedded in our products that is not covered by patent or copyright. In such
case, we may be precluded from preventing the competitor from making use of
such information. In addition, should we wish to assert our patent rights against
a particular competitors product, there can be no assurance that any claim
in any of our patents will be sufficiently broad nor, if sufficiently broad,
any assurance that our patents will not be challenged, invalidated or circumvented,
or that we will have sufficient resources to prosecute our rights.
In the normal course of business, we receive, from time to time inquiries regarding possible patent infringement. In dealing with such inquiries, it may become necessary or useful for us to obtain or grant licenses or other rights. However, there can be no assurance that such licenses or rights will be available to us on commercially reasonable terms. If we are not able to resolve a claim, negotiate a settlement of the matter, obtain necessary licenses on commercially reasonable terms and/or successfully prosecute or defend our position, our business, financial condition and results of operations could be materially and adversely affected.
Environmental Matters
We are subject to a variety of federal, state and local laws, rules and regulations relating to the use, storage, discharge and disposal of hazardous chemicals and gases used during customer demonstrations and in research and development activities. Public attention has increasingly been focused on the environmental impact of operations that use hazardous materials. In 1995, the United Kingdom adopted a new and comprehensive environmental law known as the Environmental Act 1995, which, among other things, deals with the allocation of responsibility for the clean up of contaminated property and expands potential liability with respect to the remediation of such contamination. We own or lease a number of facilities in the United Kingdom, and failure to comply with present or future regulations could result in substantial liability, suspension or cessation of our operations, restrictions on our ability to expand at our present
locations, or requirements for the acquisition of significant equipment or other significant expense. To date, compliance with environmental rules and regulations has not had a material effect on our operations. We believe that we are in material compliance with all applicable environmental rules and regulations and are in compliance with ISO14000 environmental standards.
Employees
At December 31, 2002, we had 325 full-time employees (including employees on temporary contracts), including 75 engaged in research, development and engineering, 22 in sales and marketing, 90 in customer support, 113 in manufacturing and facilities, and 25 in general administration and finance.
None of our employees are covered by a collective bargaining agreement and we consider our relations with our employees to be good.
ITEM 2. PROPERTIES
Certain information concerning our principal properties at December 31, 2002 is set forth below:
| Location |
|
Type |
|
Principal
Use |
|
Square Footage |
|
Property Interest |
|
|
|
|
|
|
|
|
|
| Newport,
United Kingdom |
|
Office,
Manufacturing & Laboratories |
|
Headquarters,
Manufacturing, Sales and Customer Support, Research & Engineering |
|
110,000 |
|
Leased |
| |
|
|
|
|
|
|
|
|
| Bristol,
United Kingdom |
|
Office,
Manufacturing & Warehouse |
|
Vacant |
|
55,700 |
|
Owned |
| |
|
|
|
|
|
|
|
|
| Cwmfelin-fach,
United Kingdom |
|
Office,
Manufacturing and Warehouse |
|
Manufacturing
of Components |
|
20,000 |
|
Leased |
| |
|
|
|
|
|
|
|
|
| Bristol,
United Kingdom |
|
Office,
Manufacturing & Warehouse |
|
Manufacturing
of Components |
|
9,000 |
|
Leased |
|
|
|
|
|
|
|
|
|
9
| Orange
County,USA |
|
Office |
|
North
American Headquarters, Sales & Support |
|
1,600 |
|
Leased |
We have a number of smaller properties and field offices located in the United States, the United Kingdom, Germany, France and South Korea. We believe that our properties adequately serve our present needs.
ITEM 3. LEGAL PROCEEDINGS
As of March 25, 2003, there were no material, pending legal proceedings to which we or our subsidiaries are a party. From time to time, we become involved in ordinary, routine or regulatory legal proceedings incidental to our business.
ITEM 4. SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS
No matters were submitted to a vote of our stockholders during the quarter ended December 31, 2002.
10
ITEM 5. MARKET FOR REGISTRANTS COMMON EQUITY AND RELATED SHAREHOLDER MATTERS
Market for the Registrants Common Equity
Our common
stock trades on the Nasdaq National Market under the symbol TRKN.
The quarterly high and low sale prices for Common Stock as reported by the Nasdaq
National Market for the periods indicated below are as follows.
|
|
|
High
|
|
Low
|
|
|
|
|
|
|
|
|
|
|
|
2001
|
|
|
|
|
|
|
|
|
First Quarter
|
|
$
|
15.63
|
|
$
|
9.44
|
|
|
Second Quarter
|
|
$
|
15.18
|
|
$
|
7.13
|
|
|
Third Quarter
|
|
$
|
14.05
|
|
$
|
7.95
|
|
|
Fourth Quarter
|
|
$
|
11.95
|
|
$
|
7.96
|
|
|
2002
|
|
|
|
|
|
|
|
|
First Quarter
|
|
$
|
15.90
|
|
$
|
10.14
|
|
|
Second Quarter
|
|
$
|
15.02
|
|
$
|
7.10
|
|
|
Third Quarter
|
|
$
|
9.13
|
|
$
|
4.01
|
|
|
Fourth Quarter
|
|
$
|
7.10
|
|
$
|
3.25
|
|
As of January 21, 2003, there were 120 holders of record of our common stock.
We have never
declared or paid dividends on our common stock and we do not expect to pay dividends
on our common stock in the foreseeable future.
Our Series
H Preferred Stock was retired during fiscal 2001. Prior to being retired, dividends
due during fiscal 2001 were paid with 12,477 new shares of Series H Preferred
Stock and cash of $50,000.
On March 18,
2003, the closing price of the common stock as reported on the Nasdaq National
Market was $3.33 per share.
Unregistered Sales of Registrants Equity Securities During Last Fiscal Year
During the year ended December 31 2002, we sold 1,093,348 shares of our common stock in a private transaction with several institutional shareholders. The gross proceeds of the sale were $12.6 million and our costs amounted to approximately $837,000.
ITEM 6. SELECTED CONSOLIDATED FINANCIAL DATA
The following selected consolidated financial data are qualified by reference to and should be read in conjunction with our consolidated financial statements and notes thereto and Managements Discussion and Analysis of Financial Condition and Results of Operations, which are included elsewhere in this report. The selected consolidated financial data set forth below as of December 31, 2002, and 2001 and for the years ended December 31, 2002, 2001, and 2000 have been derived from our audited financial statements included elsewhere in this annual report. The selected consolidated financial data set forth below as of December 31, 2000, 1999 and 1998 and for the years ended December 31, 1999 and 1998 have been derived from our audited financial statements that are not included in this annual report.
As discussed in the Managements Discussion and Analysis of Financial Condition and Results of Operations, we changed our accounting policy with respect to revenue recognition in the year ended December 31, 2001. In accordance with Accounting Principles Board Opinion 20, we accounted for the change as a cumulative effect on the prior years resulting from the change to a different revenue recognition policy. As a result, the selected consolidated financial data for the periods ending on and before December 31, 2000 have not been restated, but pro forma revenue, net income and earnings per share are included as a footnote to the selected consolidated data.
11
|
|
|
Year Ended December 31
|
|
|
|
|
|
|
|
|
|
2002
|
|
2001
|
|
2000
|
|
1999
|
|
1998
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(In thousands of U.S. dollars, except share information)
|
|
|
Operating Data:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Revenues:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Product sales
|
|
$
|
32,765
|
|
$
|
97,046
|
|
$
|
106,662
|
|
$
|
48,363
|
|
$
|
25,125
|
|
|
License revenues
|
|
|
50
|
|
|
|
|
|
350
|
|
|
2,144
|
|
|
13,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|